Validity of multiplex biomarker model of 6 genes for the differential diagnosis of thyroid nodules
2011

Multiplex Biomarker Model for Diagnosing Thyroid Nodules

Sample size: 105 publication Evidence: high

Author Information

Author(s): Ducena Kristine, Ābols Arturs, Vilmanis Janis, Narbuts Zenons, Tārs Juris, Andrējeva Diana, Linē Aija, Pīrāgs Valdis

Primary Institution: University of Latvia

Hypothesis

Can a multiplex biomarker model improve the diagnosis of thyroid nodules compared to traditional methods?

Conclusion

The study found that a multiplex biomarker model based on six genes significantly improves the differentiation between benign and malignant thyroid nodules.

Supporting Evidence

  • Significant differences in gene expression were found between normal and malignant thyroid tissues.
  • LGALS3 had the highest diagnostic value for distinguishing malignant from benign nodules.
  • The multiplex model showed 70.5% sensitivity and 93.4% specificity.

Takeaway

Researchers looked at how certain genes behave in thyroid nodules to help tell if they are cancerous or not, and found a better way to do this using a mix of six genes.

Methodology

mRNA expression levels of eight candidate marker genes were measured in paired nodular and surrounding normal thyroid tissue specimens from patients undergoing thyroid surgery.

Limitations

The study's findings need to be validated in a larger cohort of patients.

Participant Demographics

{"gender":{"male":9,"female":35},"age_mean":55,"age_sd":17}

Statistical Information

P-Value

p<0.0001

Statistical Significance

p<0.0001

Digital Object Identifier (DOI)

10.1186/1756-6614-4-11

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication